Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Project

Combination of LINC01212 and BRAF/MEK inhibition as a new therapeutic strategy for melanoma

Information

Project Team

Outputs and Outcomes

Promotor

Pieter Mestdagh

Department of Pediatrics and medical genetics (until 30 September 2018)

Pieter Mestdagh

Department of Biomolecular Medicine